Diminishing Efficacy of Combination Therapy, Response‐Heterogeneity, and Treatment Intolerance Limit the Attainability of Tight Risk Factor Control in Patients with Diabetes
- 8 March 2010
- journal article
- Published by Wiley in Health Services Research
- Vol. 45 (2), 437-456
- https://doi.org/10.1111/j.1475-6773.2009.01075.x
Abstract
To evaluate the attainability of tight risk factor control targets for three diabetes risk factors and to assess the degree of polypharmacy required. National Health and Nutrition Examination Survey-III. We simulated a strategy of "treating to targets," exposing subjects to a battery of treatments until low-density lipoprotein (LDL)-cholesterol (100 mg/dL), hemoglobin A1c (7 percent), and blood pressure (130/80 mm Hg) targets were achieved or until all treatments had been exhausted. Regimens included five statins of increasing potency, four A1c-lowering therapies, and eight steps of antihypertensive therapy. We selected parameter estimates from placebo-controlled trials and meta-analyses. Under ideal efficacy conditions, 77, 64, and 58 percent of subjects achieved the LDL, A1c, and blood pressure targets, respectively. Successful control depended highly on a subject's baseline number of treatments. Using the least favorable assumptions of treatment tolerance, success rates were 11-17 percentage points lower. Approximately 57 percent of subjects required five or more medication classes. A significant proportion of people with diabetes will fail to achieve targets despite using high doses of multiple, conventional treatments. These findings raise concerns about the feasibility and polypharmacy burden needed for tight risk factor control, and the use of measures of tight control to assess the quality of care for diabetes.Keywords
This publication has 37 references indexed in Scilit:
- Improving the Reliability of Physician Performance AssessmentMedical Care, 2009
- Beyond the Randomized Clinical TrialCirculation, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Standards of Medical Care in Diabetes—2008Diabetes Care, 2008
- The role of fibrates in the prevention of cardiovascular disease—a pooled meta-analysis of long-term randomized placebo-controlled clinical trialsAmerican Heart Journal, 2007
- Assessing Quality of Diabetes Care by Measuring Longitudinal Changes in Hemoglobin A1c in the Veterans Health AdministrationHealth Services Research, 2005
- Racial profiling - The unintended consequences of coronary artery bypass graft report cardsCirculation, 2005
- Building a Better Quality MeasureMedical Care, 2003
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998